Abstract
Five-year survival data were obtained in 97 percent or 1105 of 1140 new patients with histologically confirmed colorectal adenocarcinoma during a 12-month period in 1981 and 1982, as part of a large comprehensive population-based study of colorectal cancer incidence, etiology, and survival, The Melbourne Colorectal Cancer Study. Fifteen percent of patients were Dukes' A stage, 32 percent were Dukes' B, 25 percent were Dukes' C, and 29 percent were Dukes' D. At five years after diagnosis, the observed survival rate was 36 percent and the adjusted rate was 42 percent. Dukes' staging was a highly discriminating factor in survival ( P <0.001). Survival rates were better in women than in men and better for patients with colon cancer than for patients with rectal cancer. Survival by Dukes' staging was not affected by colon subsite or by the tumor being the first and single tumor, metachronous tumor, or synchronous tumor. The survival of younger patients was better for Dukes' stages A, B, and C, and worse for Dukes' D. Survival was worse in the presence of bowel perforation in Dukes' C and D stages. Within Dukes' D (incurable cases), survival was best in the absence of hepatic metastases, slightly worse when only hepatic metastases were present, and poorest in the presence of both hepatic and extrahepatic metastases. Statistical modeling of survival determinants other than staging indicated that cell differentiation had the largest effect (survival decreasing with poor cell differentiation), followed by site (survival worse for rectal cancer than colon cancer), then age (survival better for younger patients), while bowel perforation had the smallest effect on survival.
Similar content being viewed by others
References
Muir CS, Parkin DM. The world cancer burden: prevention or perish. Br Med J 1985;1:5–6.
Kune GA, Kune S. The Melbourne colorectal cancer study: A description of the investigation. University of Melbourne, Department of Surgery, Repatriation General Hospital publication (ISBN 0 86839 596 X) 1986:1–31.
Kune GA, Kune S. A new design to examine colorectal cancer cause and survival. Dig Surg 1987;4:156–9.
Kune S, Kune GA, Watson L. The Melbourne colorectal cancer study: incidence findings by age, sex, site, migrants and religion. Int J Epidemiol 1986;15:483–93.
Kune S, Kune GA, Watson LF. Case-control study of dietary etiological factors: the Melbourne colorectal cancer study. Nutr Cancer 1987;9:21–42.
Kune S, Kune GA, Watson LF. Case-control study of alcoholic beverages as etiological factors: the Melbourne colorectal cancer study. Nutr Cancer 1987;9:43–56.
Kune GA, Kune S, Watson LF. History of colorectal polypectomy and risk of subsequent colorectal cancer. Br J Surg 1987;74:1064–5.
Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne colorectal cancer study. Cancer Res 1988;48:4399–404.
Kune GA, Kune S, Field B, Watson LF. The role of chronic constipation, diarrhea, and laxative use in the etiology of large-bowel cancer: data from the Melbourne colorectal cancer study. Dis Colon Rectum 1988;31:507–12.
Kune GA, Kune S, Watson LF. The role of heredity in the etiology of large bowel cancer: data from the Melbourne colorectal cancer study. World J Surg 1989;13:124–31.
Kune GA, Kune S, Watson LF. Children, age at first birth and colorectal cancer risk: data from the Melbourne colorectal cancer study. Am J Epidemiol 1989;129:533–42.
Australian Bureau of Statistics. Population and Housing Census, 30 June 1981.
Dukes' CE. The classification of cancer of the rectum. J Pathol Bact 1932;35:323–32.
Dukes CE, Bussey HJR. The spread of rectal cancer and its effect on prognosis. Br J Cancer 1958;12:309–20.
SPSS-x User's Guide. New York: McGraw Hill, 1983.
Cox DR. Regression models and life tables. J Roy Statist Soc 1972;34B:187–202.
BMPD Statistical Software Manual. Univ of California Press 1985;576–94.
Whittaker M, Goligher JC. The prognosis after surgical treatment for carcinoma of the rectum. Br J Surg 1976;63:384–8.
Silverman DT, Murray JL, Smart CR, Brown CC, Myers MH. Estimated median survival times of patients with colorectal cancer based on experience with 9745 patients. Am J Surg 1977;133:289–97.
Gill PG, Morris PJ. The survival of patients with colorectal cancer treated in a regional hospital. Br J Surg 1978;65:17–20.
Stewart RJ, Robson RA, Stewart AW, Stewart JM, MacBeth WA. Cancer of the large bowel in a defined population: Canterbury, New Zealand 1970–4. Br J Surg 1979;66:309–14.
Clarke DN, Jones PF, Needham CD. Outcome in colorectal carcinoma: seven year study of a population. Br Med J 1980;1:431–5.
McDermott FT, Hughes ES, Pihl E, Milne BJ, Price AB. Comparative results of surgical management of single carcinomas of the colon and rectum: a series of 1939 patients managed by one surgeon. Br J Surg 1981;68:850–5.
Mettlin C, Natarajan N, Mittelman A, Smart CR, Murphy GP. Management and survival of adenocarcinoma of the rectum in the United States: results of a national survey by the American College of Surgeons. Oncology 1982;39:265–73.
Jolly KD, Scott JP, MacKinnon MJ, Clarke AM. Diagnosis and survival in carcinoma of the large bowel. Aust NZ J Surg 1982;52:12–6.
Cohen JR, Theile DE, Evans EB, Quinn RL, Davis NC. Colorectal cancer at the Princess Alexandra Hospital: a prospective study of 729 cases. Aust NZ J Surg 1983;53:113–9.
Chapuis PH, Pheils MT, Dunn D, Bokey EL, Newland RC, Colquhoun K. Mortality, morbidity and survival after colectomy for colon cancer. Aust NZ J Surg 1983;53:223–8.
Bear HD, MacIntyre J, Burns HJ, Jarrett F, Wilson RE. Colon and rectal carcinoma in the west of Scotland. Am J Surg 1984;147:441–6.
Umpleby HC, Bristol JB, Rainey JB, Williamson RC. Survival of 727 patients with single carcinomas of the large bowel. Dis Colon Rectum 1984;27:803–10.
Stower MJ, Hardcastle JD. The results of 1115 patients with colorectal cancer treated over an 8 year period in a single hospital. Eur J Surg Oncol 1985;11:119–23.
Isbister WH, Fraser J. Survival following resection for colorectal cancer: a New Zealand national study. Dis Colon Rectum 1985;28:725–7.
Davis NC, Evans EB, Cohen JR, Theile DE, Job DM. Colorectal cancer: a large unselected Australian series. Aust NZ J Surg 1987;57:153–9.
Slaney G. Results of treatment of carcinoma of the colon and rectum. In: Irvine WT, ed. Modern trends in surgery. 3rd ed. London:Butterworths, 1971:69–89.
Turnbull RB, Kyle K, Watson FB, Spratt J. Cancer of the colon: the influence of the no touch isolation technique on survival rates. Ann Surg 1967;166:420–5.
Davis NC, Newland RC. The reporting of colorectal cancer: the Australian clinico-pathological staging system. Aust NZ J Surg 1982:52:395–7.
Davis NC, Newland RC. Terminology and classification of colorectal adenocarcinoma: the Australian clinico-pathological staging system. Aust NZ J Surg 1983:53:211–21.
Pihl EA, Nairn RC, Hughes ES, Cuthbertson AM, Rollo AJ. Mucinous colorectal carcinoma: immunopathology and prognosis. Pathology 1980;12:439–47.
Author information
Authors and Affiliations
About this article
Cite this article
Kune, G.A., Kune, S., Field, B. et al. Survival in patients with large-bowel cancer. Dis Colon Rectum 33, 938–946 (1990). https://doi.org/10.1007/BF02139103
Issue Date:
DOI: https://doi.org/10.1007/BF02139103